期刊文献+

逆转录酶抑制剂对恶性胶质瘤细胞端粒酶活性和细胞增殖的影响

The effects of AZT on the telomerase activity and proliferation in malignant glioma cells
暂未订购
导出
摘要 目的研究逆转录酶抑制剂(AZT)对胶质瘤细胞端粒酶活性、细胞增殖和细胞周期的影响,为以端粒酶为靶点治疗脑胶质瘤提供理论和实验依据。方法采用MTT法检测AZT对细胞生长增殖的影响。用TRAP-PCR-ELISA法检测端粒酶活性的变化。用流式细胞仪检测细胞周期的改变。结果与对照组比较,12h后1.0molLAZT组的端粒酶活性降低(P<0.05),24h时0.5molLAZT组细胞生长增殖受抑制(P<0.05),1.0molLAZT组则呈现出显著性差异(P<0.01),在实验范围内,呈时间-剂量依赖性。实验组细胞周期中各时相的细胞分布发生改变,0.5molLAZT组细胞多阻滞于G2M期,而1.0molLAZT组细胞G1期增多,S期细胞数减少。结论逆转录酶抑制剂能够有效地抑制胶质瘤细胞的端粒酶活性,抑制细胞的增殖,参与了细胞周期及凋亡的调控,具有较好的应用前景。 Objective To investigate the effects of AZT on telomerase activity and proliferation in malignant glioma cell line, so as to gain further insight about telomerase as the anti - cancer target of the therapy. Methods 1WIT method was used to detect the cell survival rate. Telomeric repeat amplification protocol (TRAP) - ELISA was used to examine the telomerase activity. Ceil apoptosis rote and the phases of ceil cycle were determined by flow cytometry (FCM). Results Compared with the control, addition of Azr inhibited telomerase activity and cell proliferation in time - dependent ( 12 h vs. 24 h) and dose - dependent (0.5 mol/L vs. 1.0 mol/L) manners (P 〈 0.05 -0.01 ). AZT changed the normal pattern of cell cycle:in 0.5 mol/L group, most ceils were arrested at G2/M phase; while in 1.0 mol/L grouop, G1 phase ceils were increased and S phase cells were decreased. Conclusion AZT inhibits glioma ceil proliferation and telomerase activity, takes part in regulating ceil cycle and ceil apoptosis, and therefore, will have the potential to play a role in glioma treatment.
出处 《徐州医学院学报》 CAS 2005年第4期283-286,共4页 Acta Academiae Medicinae Xuzhou
基金 徐州医学院附属医院科研基金资助课题(200204)
关键词 逆转录酶抑制剂 胶质瘤 C6细胞 端粒酶 AZT glioma C6 cell telomerase
  • 相关文献

参考文献7

  • 1Neidle S, Kelland LR. Telomerase as an anti- cancer target: current status and future prospects[J]. Anticancer Drug Des, 1999,14(4): 341- 347.
  • 2Komata T, Kanzawa T, Kondo Y, et al. Telomerase as a therapeutic target for malignant gliomas[J]. Oncogene,2002,21 (4) :656 - 663.
  • 3Newbold RF. The significance of telomerase activation and cellular immortalization in human cancer[ J ]. Mutagenesis, 2002, 17 (6): 539 -550.
  • 4刘平,LU Yicheng,卢亦成,袁国梁,朱诚,夏放.端粒酶活性及其结构基因在人脑胶质瘤中的表达[J].中华实验外科杂志,2001,18(2):147-149. 被引量:2
  • 5Narishetty ST, Panchagnula R. Transdermal delivery system for zidovudine:in vitro,ex vivo and in vivo evaluation[J]. Biopharm Drug Dispos,2004,25(1) :9 - 20.
  • 6Yamaguchi F,Morrison RS,Takahashi H,et al. Anti- telomerase therapy suppressed glioma proliferation[ J ]. Oncol Rep, 1999,6 ( 4 ): 773 -776.
  • 7Neidle S, Parkinson G. Telomere maintenance as a target for anticancer drug discovery[ J]. Nat Rev Drug Discov, 2002,1 (5) :383 - 393.

二级参考文献2

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部